Calliditas Therapeutics

Calliditas Therapeutics company information, Employees & Contact Information

Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products.

Company Details

Employees
237
Founded
-
Address
D5, Kungsbron 1, Stockholm,stockholm County,sweden
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Stockholm, Stockholm County
Looking for a particular Calliditas Therapeutics employee's phone or email?

Calliditas Therapeutics Questions

News

Welcome Calliditas Therapeutics • New Industrial partner in SweDeliver - Uppsala universitet

Welcome Calliditas Therapeutics • New Industrial partner in SweDeliver Uppsala universitet

New Biomarker, Subgroup Analyses of Phase 3 NefIgArd Trial for Budesonide - HCPLive

New Biomarker, Subgroup Analyses of Phase 3 NefIgArd Trial for Budesonide HCPLive

FDA grants full approval of Tarpeyo for IgA nephropathy - Healio

FDA grants full approval of Tarpeyo for IgA nephropathy Healio

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy - ScienceDirect.com

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy ScienceDirect.com

FDA Awards Full Approval to Budesonide (Tarpeyo) in Treatment of IgA Nephropathy - HCPLive

FDA Awards Full Approval to Budesonide (Tarpeyo) in Treatment of IgA Nephropathy HCPLive

FDA grants Calliditas Therapeutics Accelerated Approval of Tarpeyo - PharmaLive

FDA grants Calliditas Therapeutics Accelerated Approval of Tarpeyo PharmaLive

SweDeliver is all set for pole position - Uppsala universitet

SweDeliver is all set for pole position Uppsala universitet

Top Calliditas Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant